Mallinckrodt Plc on Tuesday said it had agreed to a $1.6 billion settlement proposal in which its generic drug business would file for bankruptcy in order to resolve thousands of lawsuits alleging it helped fuel the U.S. opioid epidemic.
from Reuters: Company News https://ift.tt/32pRZKJ
via IFTTT
from Reuters: Company News https://ift.tt/32pRZKJ
via IFTTT
إرسال تعليق